Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
BRL in Millions, $ in Millions
12 Months Ended
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Operating activities:      
Consolidated net income $ 598.0 $ 495.1 $ 434.8
Adjustments to reconcile consolidated net income to net cash provided by operating activities:      
Impairment of cost method investment 0.0 0.0 14.8
Depreciation and amortization 290.9 268.7 200.0
Stock-based compensation expense 38.3 37.1 38.4
Excess tax benefits from stock-based compensation plans 0.0 (35.9) (30.0)
Deferred income taxes (44.1) (13.0) (28.7)
Changes in assets and liabilities, excluding effects of acquisitions:      
Accounts receivable, net (1.3) (55.7) (26.9)
Other assets, current and long-term (120.1) 0.3 15.9
Current and long-term liabilities, excluding debt 54.3 126.4 150.8
Cash provided by operating activities 816.0 823.0 769.1
Investing activities:      
Capital expenditures (218.2) (173.5) (146.2)
Acquisitions, net of cash acquired (139.9) (1,791.6) (4.4)
Cash received from sale of asset 8.6 0.0 0.0
Cash received from divestitures 0.0 0.0 2.9
Economic hedges 0.0 (10.8) 0.0
Investment in unconsolidated affiliates, net 0.0 0.0 (0.1)
Cash used in investing activities (349.5) (1,975.9) (147.8)
Financing activities:      
Net short-term borrowings (repayments) 252.4 73.0 (331.0)
Payments on long-term debt (322.5) (350.0) 0.0
Proceeds from issuance of long-term debt 100.0 1,574.7 0.0
Treasury stock purchases (77.1) 0.0 (196.3)
Dividends paid to Equifax shareholders (187.4) (157.6) (137.8)
Dividends paid to noncontrolling interests (8.4) (5.8) (6.4)
Proceeds from exercise of stock options 19.2 31.5 34.4
Payment of taxes related to settlement of equity awards (33.5) (27.2) (27.0)
Excess tax benefits from stock-based compensation plans 0.0 35.9 30.0
Payment of contingent consideration (3.5) (4.4) 0.0
Purchase of redeemable noncontrolling interests (2.6) (3.6) 0.0
Debt issuance costs (0.3) (6.2) (4.9)
Cash (used in) provided by financing activities (263.7) 1,160.3 (639.0)
Effect of foreign currency exchange rates on cash and cash equivalents 4.3 28.6 (17.3)
Increase (decrease) in cash and cash equivalents 207.1 36.0 (35.0)
Cash and cash equivalents, beginning of period 129.3 93.3 128.3
Cash and cash equivalents, end of period $ 336.4 $ 129.3 $ 93.3